Fundraising FoxTime BioVentures — Full Portfolio
17 tracked investments · listed companies and verified rows first
BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Oguzhan Atay, PhD(Co-Founder, CEO, and Board Chair)inDavid Tsao, PhD(Co-Founder, CTO, and Board Member)inOguzhan Atay(Founder)inDavid Tsao(Founder/CTO)inSukrit Silas(Cofounder)in
Co-investors500 Emerging Europe500 GlobalAsymmetry VenturesCivilization Ventures Management, Llce2vcFifty Years+15 more
Aquea Health works in healthcare innovation, with a focus on developing innovative solutions for patients, particularly in ophthalmology and related therapeutic areas.
HardwareHealthtechMedical Devices
Andy(Founder and CEO)Charles(CEO)DanMark
Brightside provides remote mental health care combining personalized psychiatry and therapy through a technology-enabled platform.
Digital HealthHealthtechMental HealthSan Francisco, US
Jeremy Barth(Executive Officer, Director)inBrad Kittredge(Founder)in
BoardEric Wiesen(Director)inAike Ho(Director)in
Co-investorsBullpen CapitalACME CapitalEastward Capital PartnersObvious VenturesRosecliff VenturesSlow Ventures+4 more
Commons produces CBD gummies marketed for relaxation and wellness purposes, sold direct-to-consumer through their online store.
ConsumerDirect to ConsumerWellness & Fitness
BoardTahira
Co-investorsEmles Venture PartnersCourtside VenturesFloating PointRA CapitalSteelSky Ventures
Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs.
Digital HealthHealthtechWellness & FitnessAustin, US
Brad Hively(Director)inNick Aubin(Founder)inPaulo Marques Da Costa(Executive Officer, Director)Prithviraj Singha Roy(Director)in
BoardJohn Loser(Director)inDavid Berry(Director)
Co-investorsCourtside VenturesFloating PointNorth South VenturesSteelSky VenturesAverin CapitalRA Capital+1 more
Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.
AI & Machine LearningDeep TechHealthtechMedical DevicesRobotics
Alan Murray(Founder & CEO)inAlejandro Chavez-Badiola, MD(Founder & Chief Medical Officer)inJoshua Abram(Founder)in
Co-investorsACME CapitalAdvance Venture PartnersArtis VenturesFuture Positive CapitalMuse CapitalACME
Develops software tools for researchers to conduct scientific analysis and answer biological research questions.
AI & Machine LearningBiotechDeep TechDeveloper Tools
Co-investorsAlbionVCMetaplanetMosaic Ventures
Iterative Health is a healthcare technology and services company that combines clinical trial expertise with AI to help research teams and study sponsors expand and speed up patients' access to novel therapeutics.
AI & Machine LearningBiotechHealthtechCambridge, US
Jonathan Ng(Executive Officer, Director)in
BoardPeter Moran(Director)Nan Li(Director)Charles Cooney(Director)
Co-investorsBreyer CapitalG Vision CapitalGV (Google Ventures)IKJ CapitalInsight PartnersIntrepid Growth Partners+10 more
mPharma operates a network of pharmacies across Africa that uses technology to negotiate lower drug prices with manufacturers and manage prescription information and payments.
B2B MarketplacesDigital HealthHealthtechLogistics & Supply Chain
Co-investors4DX VenturesBreyer CapitalOTVPeregrine VenturesThe Raba PartnershipTimon Capital+3 more
Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.
BiotechFremont, US
ELON MUSK(Executive Officer)in
BoardJared Birchall(Executive Officer, Director)
Co-investorsAdvaita CapitalAurum Venture PartnersBeyond CapitalDreamers VCFounders FundGestio Capital+26 more
Phantom Neuro develops a minimally invasive, subcutaneous muscle-computer interface that uses under-the-skin sensors and on-device AI to translate muscle signals into control commands for robotic devices.
AI & Machine LearningBiotechMedical DevicesRoboticsAustin, US
Connor Glass(Executive Officer, Director, Promoter)in
BoardD.A. Wallach(Director)inEdward Michael(Director)inRobert Lord(Director)in
Co-investorsBreakout VenturesDraper AssociatesLionBird
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in
Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalMitsui Global InvestmentRecode Ventures+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Deep SightDeepSightKlingNanoMosaicStealth Co (Therapeutics)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.